Oxidative Stress Is Linked to ERK1/2-p16 Signaling-mediated Growth Defect in ATM-deficient Astrocytes*

AUTOR(ES)
FONTE

American Society for Biochemistry and Molecular Biology

RESUMO

The gene that encodes the ATM protein kinase is mutated in ataxia-telangiectasia (A-T). One of the prominent features of A-T is progressive neurodegeneration. We have previously reported that primary astrocytes isolated from Atm-/- mice grow slowly and die earlier than control cells in culture. However, the mechanisms for this remain unclear. We show here that intrinsic elevated intracellular levels of reactive oxygen species (ROS) are associated with the senescence-like growth defect of Atm-/- astrocytes. This condition is accompanied by constitutively higher levels of ERK1/2 phosphorylation and p16Ink4a in Atm-/- astrocytes. We also observe that ROS-induced up-regulation of p16Ink4a occurs correlatively with ERK1/2-dependent down-regulation and subsequent dissociation from chromatin of Bmi-1. Furthermore, both mitogen-activated protein kinase (MAPK)/ERK inhibitor PD98059 and antioxidant N-acetyl-l-cysteine restored normal proliferation of Atm-/- astrocytes. These results suggest that ATM is required for normal astrocyte growth through its ability to stabilize intracellular redox status and that the inability to control ROS is the molecular basis of limited cell growth of Atm-/- astrocytes. This defect may be mediated by a mechanism involving ERK1/2 activation and Bmi-1 derepression of p16Ink4a. These data identify new potential targets for therapeutic intervention in A-T neurodegeneration.

ACESSO AO ARTIGO

Documentos Relacionados